Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Enanta Pharmaceutica
(NQ:
ENTA
)
12.62
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enanta Pharmaceutica
< Previous
1
2
3
4
5
6
7
Next >
Enanta Pharmaceuticals to Participate in Investor Conferences in September
September 03, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
ENTA Stock Earnings: Enanta Pharma Beats EPS, Beats Revenue for Q3 2024
August 05, 2024
ENTA stock results show that Enanta Pharma beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
Via
InvestorPlace
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter
August 05, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
May 29, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Recap: Enanta Pharma Q1 Earnings
February 07, 2024
Via
Benzinga
Earnings Scheduled For February 7, 2024
February 07, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
Via
Benzinga
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
May 07, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
ENTA Stock Earnings: Enanta Pharma Misses EPS, Beats Revenue for Q2 2024
May 06, 2024
ENTA stock results show that Enanta Pharma missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
May 06, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 30, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Earnings Preview For Enanta Pharma
February 06, 2024
Via
Benzinga
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
April 30, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
April 29, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
April 17, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Inc. (NASDAQ: ENTA) Near the Top of Equities by Percentage Gain on 11/21
November 21, 2023
Via
Investor Brand Network
What 5 Analyst Ratings Have To Say About Enanta Pharma
November 21, 2023
Via
Benzinga
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
March 06, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
February 07, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 06, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Recap: Enanta Pharma Q4 Earnings
November 20, 2023
Via
Benzinga
Enanta Pharma Earnings Preview
November 17, 2023
Via
Benzinga
Analyst Expectations for Enanta Pharma's Future
October 23, 2023
Via
Benzinga
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
January 31, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
January 04, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conference
November 22, 2023
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 21, 2023
Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the...
Via
Benzinga
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2023, with Webcast and Conference Call Today at 4:30 p.m. ET
November 20, 2023
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Earnings Scheduled For November 20, 2023
November 20, 2023
Companies Reporting Before The Bell • Greenland Technologies (NASDAQ:GTEC) is projected to report quarterly earnings at $0.05 per share on revenue of $24.26 million.
Via
Benzinga
Enanta Pharmaceuticals to Host Conference Call on November 20 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Full Year Ended September 30, 2023
November 13, 2023
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.